The digital health company’s vocal biomarker ... of early-stage Alzheimer’s and other forms of dementia. The hope is that vocal biomarkers could be used to monitor the progression of people ...

Elevated levels of p-tau 181 and 217 in cerebrospinal fluid are considered to reflect early Alzheimer's disease pathology.

A recent perspective offered guidance to clinician’s in managing how or in some cases whether to disclose a diagnosis of ...

Researchers at the University of Pittsburgh have devised a biomarker test that can spot small amounts of clumping tau protein in the brain and cerebrospinal fluid, which lead to Alzheimer's disease.

step 2 determines that the dementia is due to AD, step 3 provides an increased level of certainty to the diagnosis, and step 4 evaluates the biomarker probability of AD etiology. The next idea ...

Of respondents, 81% were aware that they could undergo blood biomarker testing and about half were concerned about stigma if the tests showed they were at risk for a form of dementia. About a ...

The free clinical trial at Axiom Brain Health in Tampa works to detect early signs of Alzheimer's and other cognitive ...